Final Project - BIO-2510-jan23

Download as pdf or txt
Download as pdf or txt
You are on page 1of 7

Covid -19 1

COVID - 19

BIO-2510: INTRODUCTION TO MICROBIOLOGY WITH LAB

Final Project

Delia Johnson

Thomas Edison State University

BIO 2510 OL 009

Ingrid Herrmann
Covid -19 2

COVID - 19

Introduction

A noticeable occurrence of the 21st century, the COVID-19 pandemic has affected the

economy and healthcare worldwide. SARS prevention and therapy need a good knowledge of the

SARS-CoV-2 virus. This publication relies on the CDC, WHO, and peer-reviewed sources to give

reliable advice on SARS-CoV-2 subjects. These topics include its discovery, replication, treatment

choices, and control measures.

SARS-CoV-2 Identification

1. Early in the pandemic, researchers suspected that a virus caused COVID-19. What are some

ways that they could confirm that a virus, and not bacteria, was responsible for this disease?

Researchers could confirm a virus caused by COVID-19 through methods like PCR testing for

viral RNA and electron microscopy to visualize viral particles (CDC, 2020).
Covid -19 3

2. What type of microscopy would be needed to view SARS-CoV-2? Why? What cell type or

organelle would be of an equivalent size to this virus?

Electron microscopy would be required to view SARS-CoV-2 due to its small size, comparable to

cellular organelles like vesicles (WHO, 2020).

3. Based on the Baltimore classification of viruses, which groups would SARS-CoV-2 fall

within? What type of genetic material does it contain? Are there any related viruses that

cause disease in humans?

SARS-CoV-2 falls within Group IV of the Baltimore classification because it has a single-stranded

RNA genome; related viruses include SARS-CoV and MERS-CoV (Pilz et al., 2022).

SARS-CoV-2 Replication and Genetics

4. Based on your response to question three, draw the replication cycle of SARS-CoV-2.

The replication cycle of SARS-CoV-2 involves attachment, entry, RNA replication, assembly, and

release (Artica et al., 2020).

5. How could SARS-CoV-2 be cultivated? What biological materials would be needed?

SARS-CoV-2 can be cultivated using mammalian cell cultures and a specific growth medium

(Khanal, 2020).

6. If viruses such as SARS-CoV-2 cannot metabolize organic molecules, where do they get

the energy to undergo replication?

SARS-CoV-2 hijacks the host cell's machinery to obtain energy for replication, as it lacks

metabolic pathways (CDC, 2020).


Covid -19 4

7. As discussed above, SARS-CoV-2 has an RNA genome. Discuss three differences between

RNA and DNA.

Three differences between RNA and DNA include RNA being single-stranded, containing uracil

instead of thymine, and less stable (Artica et al., 2020).

8. During the course of the pandemic, several variants of the original SARS-CoV-2 virus have

become dominant strains circulating through human populations. Discuss the steps that are

involved with the formation of a variant and its increase in prevalence.

Variants arise through mutations, selection for increased transmissibility or immune evasion, and

spread through the population (Pilz et al., 2022).

COVID-19 Treatments

9. One of the few drugs that have been found to be effective against SARS-CoV-2 is

remdesivir. How does this drug inhibit viral replication?

Remdesivir inhibits the viral RNA polymerase enzyme, thereby blocking replication (Khanal,

2020).

10. Predict which physical or chemical methods of control would be effective against viruses

like SARS-CoV-2. List two physical or chemical methods and their mechanism of action.

UV light, which damages viral RNA, and ethanol, which disrupts the viral envelope, are effective

against SARS-CoV-2 (WHO, 2020).

11. What are at least two suspected reservoirs for SARS-CoV-2, besides humans?
Covid -19 5

Besides humans, suspected reservoirs for SARS-CoV-2 include bats and pangolins (Artica et al.,

2020).

12. How can SARS-CoV-2 be transmitted? For each transmission mechanism, discuss whether

this is a potential source of transmission.

Direct contact yes

Indirect contact yes

Vehicle yes

Vector no

SARS-CoV-2 can be transmitted via direct contact, indirect contact, and vehicles like air; vectors

are not likely involved (CDC, 2020).

13. Why is quarantine a crucial tool used by public health to reduce the spread of COVID-19?

Quarantine is crucial for reducing spread as it isolates potential carriers, breaking the chain of

transmission (WHO, 2020).

14. How can herd immunity prevent the spread of viruses within a human population?

Herd immunity prevents the spread by ensuring a high enough percentage of the population is

immune, thus reducing the number of susceptible hosts (Pilz et al., 2022).
Covid -19 6

15. Some of the first vaccines developed for COVID-19 were RNA vaccines. After the

administration of the vaccine, how does this result in an immune response if exposed to the

actual virus?

RNA vaccines introduce mRNA that is translated into a spike protein, triggering an immune

response, and providing protection (Khanal, 2020).

Conclusion

To effectively stop the transmission of COVID-19, it is essential to have a solid grasp of the

microbiology underlying SARS-CoV-2. Scientific studies illuminate the virus's classification,

microscopic detection, replication processes, and treatment choices. These findings aid public

health activities like vaccination and quarantine programs to boost herd immunity and reduce

transmission. Research is needed to update these methods as the virus evolves and spreads. 
Covid -19 7

References

Artika, I. M., Dewantari, A. K., & Wiyatno, A. (2020). Molecular biology of coronaviruses: current

knowledge. Heliyon, 6(8).

CDC. (2020). "COVID-19 Information and Updates." Centers for Disease Control and Prevention.

Khanal, P. (2020). Remdesivir for COVID-19 treatment: mechanism OF action, synthesis, and

clinical trials. J Pharm Pharm Sci, 9, 1062-1068.

Pilz, S., Theiler-Schwetz, V., Trummer, C., Krause, R., & Ioannidis, J. P. (2022). SARS-CoV-2

reinfections: Overview of efficacy and duration of natural and hybrid

immunity. Environmental Research, 209, 112911.

WHO. (2020). "Coronavirus disease (COVID-19) pandemic." World Health Organization.

Parker, Nina, Schneegurt, M., Thi Tu, A.-H., Lister, P., & Forester, B. M. (2016, November 12).

https://openstax.org/books/microbiology

You might also like